Jet and ultrasonic nebulization of single chain urokinase plasminogen activator (scu-PA)

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 13, Issue 4, 2000, Pages 325-333

  Munster A M B ^a   Bendstrup, E ^b   Jensen, J I ^b   Gram, J ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ESBJERG HOSPITAL   (Denmark)

Author keywords

Drug output; Enzymatic activity; Jet and ultrasonic nebulized sw PA; Particle size distribution

Indexed keywords

PROUROKINASE;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; DEVICE; DRUG INACTIVATION; ENZYME ACTIVITY; FIBRINOLYSIS; FILTER; HUMAN; INTERMETHOD COMPARISON; MEDICAL NEBULIZER; NEBULIZATION; PARTICLE SIZE;

EID: 0034493781     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.2000.13.325     Document Type: Article

References (43)

1. Acute respiratory distress in adults
2. The American-European consensus conference on ARDS
3. The adult respiratory distress syndrome: A report of survival and modifying factors
4. What is the mortality of ARDS?
5. Improved survival of patients with acute respiratory distress syndrome (ARDS) 1983-1993
6. Reduced mortality in association with the acute respiratory distress syndrome (ARDS)
7. Fibrinolysis tissue repair in the lungs
8. The microembolism syndrome a review
9. The acute respiratory distress syndrome: Fibrosis in the fast lane
10. From clot to collagen: Coagulation peptides in interstitial lung disease
11. Intravascular coagulation associated with the adult respiratory distress syndrome
12. Pulmonary fibrosis in severe acute respiratory failure
13. Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients
14. Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease
15. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome
16. Fibrinolytic activity in bronchoalveolar lavage of baboons with diffuse alveolar damage: Trends in two forms of lung injury
17. Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome
18. Depressed bronchoalveolar activity in patients with adult respiratory distress syndrome
19. Inhalation/intravenous recombinant tissue plasminogen activator and inhaled heparin in a patient with acute respiratory distress syndrome. Short communication
20. Prevention of adult respiratory distress syndrome with plasminogen activator in pigs
21. Protein measurement with the folin phenol reagent
22. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
23. Studies on the interference of selected substances with two Lowry protein determinations
24. Plasminogen activity and plasma coagulum lysis measured by use of optimized fibrin gel structure performed in microtiter plates
25. Degradation of fibrin and elastin by intact human alveolar macrophages in vitro
26. Urokinase-type plasminogen activator in alveolar macrophages and bronchoalveolar lavage fluid from normal and smoke-exposed hamsters and humans
27. Fibrinolytic properties of single chain urokinase-type plasminogen activator (pro-urokinase)
28. The science of nebulised drug delivery
29. Comparison of jet and ultrasonic nebulizer pulmonary aerosol deposition during mechanical ventilation
30. Delivery of a nebulized aerosol to a lung model during mechanical ventilation
31. Evaluation of nebulizers for use in neonatal ventilator circuits
32. Production of therapeutic aerosols: Principles and techniques
33. Physical properties of aeosols produced by several jet- and ultrasonic nebulizers
34. Characterization of heparin aerosols generated in jet and ultrasonic nebulizers
35. Comparison of drug delivery from conventional versus "Venturi" nebulizers
36. Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients. Comparison of dose to the lung
37. Aerosol delivery in intubated, mechanically ventilated patients
38. Pulmonary deposition of a nebulised aerosol during mechanical ventilation
39. The current laboratory determination of "respirable mass" is not clinically relevant
40. Combined aerosol application of urokinase and pulmonary surfactant restores gas exchanges in an isolated lung model of alveolar fibrin formation
41. Untersuchungen über die ultraschallvernebelung von oberflächeaktiven stoffen aus lungengwebe und lecithin-dispersion im hinblick auf die künstliche befilmung von lungen
42. Insulin across respiratory mucosa by aerosol delivery
43. Correspondence